Terms: = Cervical cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL AND Treatment
15 results:
1. HPV DNA Testing and Mobile Colposcopy for cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK
Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112
[TBL] [Abstract] [Full Text] [Related]
2. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Pitfall in Thyroid Practice.
Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
[TBL] [Abstract] [Full Text] [Related]
3. High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer.
Yazaki S; Kojima Y; Yoshida H; Takamizawa S; Kitadai R; Nishikawa T; Shimoi T; Sudo K; Saito A; Okuma HS; Tanioka M; Noguchi E; Uno M; Ishikawa M; Kato T; Fujiwara Y; Ohe Y; Yonemori K
J Gynecol Oncol; 2022 Nov; 33(6):e82. PubMed ID: 36245230
[TBL] [Abstract] [Full Text] [Related]
4. Modelling cervical cancer elimination using single-visit screening and treatment strategies in the context of high HIV prevalence: estimates for KwaZulu-Natal, South Africa.
Rao DW; Bayer CJ; Liu G; Chikandiwa A; Sharma M; Hathaway CL; Tan N; Mugo N; Barnabas RV
J Int AIDS Soc; 2022 Oct; 25(10):e26021. PubMed ID: 36225139
[TBL] [Abstract] [Full Text] [Related]
5. Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022.
Prudden HJ; Achilles SL; Schocken C; Broutet N; Canfell K; Akaba H; Basu P; Bhatla N; Chirenje ZM; Delany-Moretlwe S; Denny L; Gamage DG; Herrero R; Hutubessy R; Villa LL; Murillo R; Schiller JT; Stanley M; Temmerman M; Zhao F; Ogilvie G; Kaslow DC; Dull P; Gottlieb SL;
Vaccine; 2022 Sep; 40(41):5843-5855. PubMed ID: 36008233
[TBL] [Abstract] [Full Text] [Related]
6. Modelling the impact of prevention strategies on cervical cancer incidence in South Africa.
van Schalkwyk C; Moodley J; Welte A; Johnson LF
Int J Cancer; 2021 Oct; 149(8):1564-1575. PubMed ID: 34164807
[TBL] [Abstract] [Full Text] [Related]
7. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic etv6-NTRK3 gene fusion.
Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
Ann Oncol; 2019 Nov; 30 Suppl 8():viii31-viii35. PubMed ID: 32223937
[TBL] [Abstract] [Full Text] [Related]
8. [Comparison of progression-free and overall survival between endometrial cancer patients treated with laparoscopic and open surgical techniques].
Póka R; Baradács I
Orv Hetil; 2020 Mar; 161(10):382-388. PubMed ID: 32115990
[TBL] [Abstract] [Full Text] [Related]
9. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
[TBL] [Abstract] [Full Text] [Related]
10. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic etv6-NTRK3 gene fusion.
Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
Ann Oncol; 2019 Nov; 30(Suppl_8):viii31-viii35. PubMed ID: 31738425
[TBL] [Abstract] [Full Text] [Related]
11. A Case of Papillary Thyroid Carcinoma and Kostmann Syndrome: A Genomic Theranostic Approach for Comprehensive treatment.
Han S; Ehrhardt J; Shukla S; Elkbuli A; Nikiforov YE; Gulec SA
Am J Case Rep; 2019 Jul; 20():1027-1034. PubMed ID: 31308356
[TBL] [Abstract] [Full Text] [Related]
12. Protocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda.
Murenzi G; Dusingize JC; Rurangwa T; Sinayobye JD; Munyaneza A; Murangwa A; Zawadi T; Hebert T; Mugenzi P; Adedimeji A; Mutesa L; Anastos K; Castle PE
BMJ Open; 2018 Aug; 8(8):e020432. PubMed ID: 30082342
[TBL] [Abstract] [Full Text] [Related]
13. Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?
Rauh LA; Pannone AF; Cantrell LA
Gynecol Oncol; 2017 Dec; 147(3):597-600. PubMed ID: 28923411
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin.
Baghai F; Yazdani F; Etebarian A; Garajei A; Skalova A
Pathol Res Pract; 2017 Sep; 213(9):1112-1118. PubMed ID: 28781197
[TBL] [Abstract] [Full Text] [Related]
15. Review of treatment and Prognosis of Stage IVB cervical Carcinoma.
Usami T; Takahashi A; Matoda M; Okamoto S; Kondo E; Kanao H; Umayahara K; Takeshima N
Int J Gynecol Cancer; 2016 Sep; 26(7):1239-45. PubMed ID: 27643648
[TBL] [Abstract] [Full Text] [Related]
